Free Trial
OTCMKTS:GLUC

Glucose Health Q3 2025 Earnings Results & Report

Glucose Health logo
$0.34 -0.02 (-5.11%)
As of 01:24 PM Eastern

Glucose Health reported Q3 2025 earnings on October 17, 2025. The company reported EPS of -$0.01, while revenue was $0.06 million.

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
After Market Closes

Glucose Health EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Glucose Health Revenue Results

Actual Revenue
$0.06 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Glucose Health Q3 2025 Earnings FAQ

Glucose Health (OTCMKTS:GLUC) reported earnings of -$0.01 per share for Q3 2025. The report was announced on Friday, October 17, 2025.

Glucose Health reported revenue of $0.06 million for Q3 2025.

Glucose Health Earnings Headlines

8 teas that can help lower blood sugar
Trump’s Plan To Cheat History
China has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years.tc pixel
See More Glucose Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Glucose Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Glucose Health and other key companies, straight to your email.

About Glucose Health

Glucose Health (OTCMKTS:GLUC) is a consumer health company focused on developing and marketing nutritional products intended to support healthy blood glucose levels and metabolic wellness. The company’s offerings are positioned as dietary supplements and functional nutrition products rather than prescription medicines.

Its principal product has been GlucoDown, a powdered drink mix marketed for use as part of a daily wellness routine. The product is formulated with nutritional ingredients intended to support blood sugar management, and is sold directly to consumers through online channels.

Publicly available information about Glucose Health’s operating history, geographic reach, and current leadership is limited. The company’s business has primarily been associated with the development, promotion, and sale of its branded glucose-support products.

View Glucose Health Profile